Emergency department use of neuromuscular blocking agents in children

Area of Science:

• Pediatric Emergency Medicine
• Pharmacology
• Anesthesiology

Background:

• The ideal neuromuscular blocking agent for pediatric rapid sequence intubation (RSI) in emergency departments (EDs) remains elusive.
• Current options like succinylcholine offer rapid onset and short duration but carry significant risks.
• Nondepolarizing agents such as rocuronium and vecuronium are alternatives with varying profiles.

Observation:

• Succinylcholine is the only agent providing both rapid onset and ultra-short duration for pediatric RSI.
• Rocuronium demonstrates a rapid onset comparable to succinylcholine with a superior safety profile.
• Vecuronium offers minimal side effects but has a slower onset and longer recovery time compared to succinylcholine.

Findings:

• Rocuronium is frequently the preferred agent for pediatric RSI due to its safety and rapid onset, despite a longer duration.
• Vecuronium serves as a viable alternative in settings lacking rocuronium, offering a good safety profile.
• Rapacuronium shows promise for RSI in children if its safety is further validated, due to its rapid onset and short duration.

Implications:

• The choice of neuromuscular blocking agent for pediatric RSI involves balancing speed, duration, and safety.
• Rocuronium is emerging as a preferred agent for pediatric RSI in many EDs.
• Further research into agents like rapacuronium could provide improved options for pediatric emergency airway management.